INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 37 filers reported holding INMUNE BIO INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,545 | -43.4% | 8,500 | -24.1% | 0.00% | – |
| Q2 2023 | $101,696 | +98.4% | 11,200 | +41.1% | 0.00% | – |
| Q1 2023 | $51,260 | -13.1% | 7,935 | -14.2% | 0.00% | – |
| Q4 2022 | $59,000 | +55.3% | 9,250 | +52.9% | 0.00% | – |
| Q3 2022 | $38,000 | -22.4% | 6,050 | +8.9% | 0.00% | – |
| Q2 2022 | $49,000 | -82.4% | 5,557 | -83.2% | 0.00% | -100.0% |
| Q1 2022 | $279,000 | -23.4% | 33,100 | -7.4% | 0.00% | 0.0% |
| Q4 2021 | $364,000 | +53.6% | 35,738 | +193.7% | 0.00% | – |
| Q3 2021 | $237,000 | -50.5% | 12,170 | -55.4% | 0.00% | -100.0% |
| Q2 2021 | $479,000 | +409.6% | 27,262 | +241.5% | 0.00% | – |
| Q1 2021 | $94,000 | -8.7% | 7,982 | +33.0% | 0.00% | – |
| Q4 2020 | $103,000 | +66.1% | 6,000 | 0.0% | 0.00% | – |
| Q3 2020 | $62,000 | +6100.0% | 6,000 | +2900.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 200 | -33.3% | 0.00% | – |
| Q1 2020 | $1,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Westside Investment Management, Inc. | 37,105 | $239,703 | 0.07% |
| QUADRANT CAPITAL GROUP LLC | 60,000 | $387,600 | 0.04% |
| Janney Montgomery Scott LLC | 239,448 | $1,547 | 0.01% |
| Financial Advocates Investment Management | 11,500 | $74,290 | 0.01% |
| MAI Capital Management | 19,643 | $126,894 | 0.00% |
| VALLEY NATIONAL ADVISERS INC | 1,000 | $8 | 0.00% |
| NORTHERN TRUST CORP | 20,297 | $131,119 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 9,036 | $58,373 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 143,657 | $928,024 | 0.00% |